| Name |
Recombinant Human BAI2 Protein Fc Chimera, CF
|
| Supplier |
R&D Systems
|
| Catalog |
9338-BA
|
| Category |
Protein
|
| Prices |
$329.00
|
| Sizes |
50 µg
|
| Species Reactivities |
Human
|
| Nature |
Recombinant
|
| Source |
Human embryonic kidney cell, HEK293-derived Human BAI2 (Phe21-Asp911 ) Accession # O60241-3 IEGRMD Human IgG 1 (Pro100-Lys330) N-terminus C-terminus
|
| Purity |
>85%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
|
| Bioactivity |
Measured by its binding ability in a functional ELISA. When Recombinant Human C1qL3 (Catalog # 9115-TN ) is immobilized at 2 μg/mL, 100 μL/well, the concentration of Recombinant Human BAI2 Fc Chimera that produces 50% of the optimal binding response is approximately 25-150 ng/mL.
|
| Endotoxin |
<0.10 EU per 1 μg of the protein by the LAL method.
|
| SwissProt/Accession |
O60241-3
|
| Gene |
ADGRB2
|
| Sequence |
Phe21
|
| Supplier Page |
Shop
|
WhenRecombinant Human C1qL3 (Catalog # 9115-TN ) is coated at 2 µg/mL (100 μL/well), Recombinant Human BAI2 FcChimera (Catalog # 9338-BA) binds with an ED 50 of 25-150 ng/mL.